ABSTRACT
Aims/hypothesis To investigate the risk of all-cause and cause-specific mortality among participants with neither, one, or both of diabetes and depression in a large prospective cohort study in the United Kingdom.
Methods Our study population included 499,830 UK Biobank participants without schizophrenia and bipolar disorder at baseline. Type 1 or type 2 diabetes and depression were identified using self-reported diagnoses, prescribed medication and hospital records. Mortality was identified from death records using the primary cause of death to define cause-specific mortality. We performed Cox proportional hazards models to estimate the risk of all-cause mortality and mortality due to cancer, circulatory disease and causes of death other than circulatory disease or cancer among participants with either depression (n=41,791) or diabetes alone (n=22,677) and with comorbid diabetes and depression (n=3,597), compared to the group with neither condition (n=431,765) adjusting for sociodemographic and lifestyle factors, comorbidities, and history of CVD or cancer. We investigated for interaction between diabetes and depression.
Results During a median of 6.8 (IQR: 6.1 – 7.5) years of follow-up, there were 13,724 deaths (cancer (n=7,976), circulatory disease (n=2,827), and other causes (n=2,921)). Adjusted hazard ratios of all-cause mortality and mortality due to cancer, circulatory disease and other causes were highest among people with comorbid depression and diabetes (HRs 2.16, 95% CI 1.94 – 2.42; 1.62, 95% CI 1.35 – 1.93; 2.22 95% CI 1.80 – 2.73 and 3.60, 95% CI 2.93 – 4.42, respectively). Among those with comorbid diabetes and depression, the risks of all-cause, cancer and other mortality exceeded the sum of the risks due to diabetes and depression alone.
Conclusions/interpretation We confirmed the negative impact of depression and diabetes on mortality outcomes, and also identified that comorbid depression and diabetes had synergistic effects on all-cause mortality which was largely driven by deaths due to cancer and causes other than circulatory disease and cancer.
What is already known about this subject?
- Comorbid depression is common in individuals with diabetes and associated with increased risks of all-cause and cardiovascular mortality
- The mortality risk among people with comorbid diabetes and depression might exceed the sum of the risks associated with each disorder alone
- There is limited knowledge about the individual and joint effects of depression and diabetes on risk of death from specific causes.
What is the key question?
- What is the risk of all-cause and cause-specific mortality associated with neither, one, or both of diabetes (of any type) and depression?
What are the new findings?
- In a large prospective cohort study in the United Kingdom, comorbid depression and diabetes had synergistic effects on all-cause mortality which was largely driven by deaths due to cancer and causes other than circulatory disease and cancer
How might this impact on clinical practice in the foreseeable future?
- These findings help identify individuals at high risk of adverse events, and suggest a need for cost-effective interventions to support psychological well-being and risk reduction in people with diabetes
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
RP is a PhD scholar funded by the University of Edinburgh. Access to the UK Biobank data was funded by a University of Queensland Early Career Researcher grant, awarded to CAJ.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Analyses of UK Biobank data are conducted under generic approval from the NHS National Research Ethics Service (Ref 11/NW/0382, approval letter dated 17 June 2011).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Details of co-authors: Sarah H. Wild, Email: sarah.wild{at}ed.ac.uk, Caroline A. Jackson, Email: caroline.jackson{at}ed.ac.uk
Tweet: Comorbid depression and diabetes had synergistic effects on all-cause mortality, largely driven by deaths due to cancer and causes other than circulatory disease and cancer. @EdinburghUni @EdinUniUsher @uk_biobank
Data Availability
All bona fide researchers in academic, commercial, and charitable settings can apply to use the UK Biobank resource for health-related research in the public interest (www.ukbiobank.ac.uk/register-apply/).
ABBREVIATIONS
- AP
- Attributable proportion due to interaction
- RERI
- Relative excess risk due to interaction
- S
- Synergy index
